Anaptysbio (ANAB) Asset Utilization Ratio (2017 - 2026)
Anaptysbio (ANAB) posted Asset Utilization Ratio of 0.5 for Q1 2026, up 2.07% on a QoQ basis from 0.49 in Q4 2025, and up 186.45% year-over-year from 0.17 in Q1 2025.
Anaptysbio (ANAB) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
Anaptysbio's Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.5 for Q1 2026.
- Quarterly Asset Utilization Ratio rose 186.45% year-over-year to 0.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.5 (up 186.45% YoY) and the FY2025 annual result came in at 0.55, up 183.68% from the prior year.
- Asset Utilization Ratio was 0.5 for Q1 2026 at Anaptysbio, up from 0.49 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.5 in Q1 2026 and bottomed at 0.01 in Q3 2022.
- A 5-year average of 0.14 and a median of 0.07 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio tumbled 97.16% — and 2025, when it surged 309.98%.
- Anaptysbio's Asset Utilization Ratio stood at 0.01 in 2022, then surged by 164.61% to 0.04 in 2023, then soared by 225.91% to 0.12 in 2024, then jumped by 309.98% to 0.49 in 2025, then gained by 2.07% to 0.5 in 2026.
- Business Quant data shows ANAB's Asset Utilization Ratio at 0.5 in Q1 2026, 0.49 in Q4 2025, and 0.36 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | 0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.50 |
| Dec 31, 2025 | 0.49 |
| Sep 30, 2025 | 0.36 |
| Jun 30, 2025 | 0.24 |
| Mar 31, 2025 | 0.17 |
| Dec 31, 2024 | 0.12 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.07 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | 0.26 |
| Jun 30, 2021 | 0.22 |